TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / SPONSORED ADS
Total 13F shares
85,210,658
Share change
+7,429,893
Total reported value
$1,247,493,378
Put/Call ratio
7.8%
Price per share
$14.64
Number of holders
324
Value change
+$106,067,914
Number of buys
186
Number of sells
117

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2025

As of 30 Sep 2025, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 324 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,210,658 shares. The largest 10 holders included Capital Research Global Investors, MORGAN STANLEY, UBS Group AG, GOLDMAN SACHS GROUP INC, FMR LLC, BRANDES INVESTMENT PARTNERS, LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., TORONTO DOMINION BANK, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. This page lists 324 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.